Extrapyramidal symptoms (EPS) represent a range of movement disorders that arise primarily as adverse effects of certain medications, notably antipsychotics and some antiemetics. These symptoms are a range of motor disturbances, including dystonia, akathisia, parkinsonism, and tardive dyskinesia, which can significantly impair patients' quality of life and treatment adherence. Understanding the underlying mechanisms behind EPS is crucial for clinicians and patients. Managing EPS requires a comprehensive approach, incorporating pharmacological interventions, dose adjustments, and sometimes switching to alternative medications with lower EPS liability. Recognising and addressing the different impacts of EPS is crucial for comprehensive patient care, necessitating tailored treatment options to alleviate symptoms and mitigate their broader repercussions.

What are extrapyramidal symptoms (EPS)?

Extrapyramidal symptoms refer to a range of involuntary movement disorders and related side effects that are often associated with the use of antipsychotic medications. These symptoms can appear in various forms, including tremors, dystonia, akathisia, and tardive dyskinesia. It’s important to note that while EPS is most commonly linked to antipsychotics, it can also occur as a result of other medications or medical conditions.

Causes of EPS

The primary cause of EPS is the use of certain medications, particularly first-generation antipsychotics such as haloperidol and chlorpromazine.

These medications block dopamine receptors in the brain, disrupting the regulation of motor function and coordination and resulting in the development of EPS.

Types of extrapyramidal symptoms

Some common types of EPS include:

Dystonia: This condition is characterised by sustained muscle contractions, leading to repetitive or twisting movements and abnormal postures. It commonly affects the neck muscles (cervical dystonia), causing involuntary neck twisting or spasms.
Akathisia: Individuals experiencing akathisia often feel restless and unable to sit still. This can lead to a constant need to move around, accompanied by inner tension and agitation.
Tardive Dyskinesia: Tardive dyskinesia is a potentially irreversible condition characterised by repetitive, involuntary movements, particularly involving the face, lips, tongue, and extremities. These movements can range from mild to severe and significantly impact an individual's daily functioning.

Preventing and Managing Extrapyramidal Symptoms

Here are some ways to prevent and manage EPS.

Medication adjustments: In cases where antipsychotic medications trigger EPS, healthcare providers may consider adjusting the dosage or switching to second-generation antipsychotics, which are associated with a lower risk of EPS.

Anticholinergic medications: Certain anticholinergic drugs, such as benztropine or trihexyphenidyl, can help alleviate EPS by reducing the activity of acetylcholine, a neurotransmitter that is overactive in some forms of EPS.

Behavioural strategies: Relaxation techniques, mindfulness, and physical activities can help manage some of the discomfort associated with EPS, particularly akathisia.

Close monitoring and communication: Regular monitoring by healthcare providers and open communication about any emerging symptoms is crucial for early intervention and effective management of EPS.

Conclusion

Extrapyramidal symptoms can present significant challenges for individuals taking antipsychotic medications. Understanding the causes and types of EPS, as well as implementing appropriate prevention and management strategies, is essential to minimising the impact of these side effects on an individual’s well-being.

References

https://www.webmd.com/schizophrenia/what-are-extrapyramidal-effects
https://www.healthline.com/health/symptom/extrapyramidal-symptoms